8-hydroxyquinoline derivative iridium (III) complex as well as preparation method and application thereof

A technology of hydroxyquinoline and derivatives, applied in the field of medicine, to achieve high anti-tumor activity and good target inhibition effect

Active Publication Date: 2021-04-20
YULIN NORMAL UNIVERSITY
View PDF11 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But there is no iridium metal complex reported by 8-hydroxyquinoline derivatives

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 8-hydroxyquinoline derivative iridium (III) complex as well as preparation method and application thereof
  • 8-hydroxyquinoline derivative iridium (III) complex as well as preparation method and application thereof
  • 8-hydroxyquinoline derivative iridium (III) complex as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] (1) 8-hydroxyquinoline derivative iridium (Ⅲ) complex [Ir (3a) (BQ) 2 ] preparation and characterization:

[0040] Such as Image 6 As shown, weigh compound 4 and compound 3a (8-hydroxyquinoline derivative) according to the molar ratio of 1:1.5, put them into the container, then add ethylene glycol, heat and reflux for 13h under the protection of argon, and obtain a dark red clear solution ; Cool to room temperature, add water to dilute, and then add saturated ammonium hexafluorophosphate solution, which produces a large amount of red precipitate; filter with suction, wash with water and ether, and dry; dissolve the dried crude product with acetonitrile, and filter with neutral alumina Column separation; use V (dichloromethane): V (acetonitrile) = 3: 1 mixed solvent to collect the yellow component, then distill under reduced pressure and spin dry to remove the solvent to obtain a khaki solid product, which is 8-hydroxyquinoline Phyloline derivatives iridium (Ⅲ) comple...

Embodiment 2

[0052] 8-Hydroxyquinoline derivatives iridium (Ⅲ) complexes [Ir (3a) (BQ) 2 ] The synthetic route such as Image 6 Shown:

[0053] (1) Preparation of compound 1: add 600mL of concentrated hydrochloric acid (pre-placed in the refrigerator to freeze, the concentration of concentrated hydrochloric acid is at 37% volume fraction) and 14.5g of 8-hydroxyquinoline in a 1L round bottom flask, and heat the temperature to 40°C , after the 8-hydroxyquinoline is completely dissolved, add 53g NaClO in batches 3 (The addition was completed within 60 minutes), and after the addition was completed, the stirring was continued at 40° C. for 2 h. After the reaction was completed, dilute to 2L with ice water and dilute with CH 2 Cl 2 (6 × 250mL) extraction, combined organic phase, washed with 3 × 200mL of distilled water, vacuum rotary evaporation of the solvent to obtain a yellow solid, filtered the precipitate, and the solid was recrystallized three times with 40mL of methanol to obtain 6,7...

Embodiment 3

[0059] 8-Hydroxyquinoline derivatives iridium (Ⅲ) complexes [Ir (3a) (BQ) 2 ] The synthetic route such as Image 6 Shown:

[0060] (1) Preparation of compound 1: carefully add 725mL of concentrated hydrochloric acid (placed in the refrigerator to freeze in advance, the concentration of concentrated hydrochloric acid is at 35% volume fraction) and 14.5g of 8-hydroxyquinoline in a 1L round bottom flask, and heat to 45 ℃, after the 8-hydroxyquinoline is completely dissolved, add 64g NaClO in batches 3 (The addition was completed within 60 minutes), and after the addition was completed, the stirring was continued at 45° C. for 1 h. After the reaction was completed, dilute to 2L with ice water and dilute with CH 2 Cl 2 (6 × 250mL) extraction, combined organic phase, washed with 3 × 200mL of distilled water, vacuum rotary evaporation of the solvent to obtain a yellow solid, filtered the precipitate, and the solid was recrystallized three times with 40mL of methanol to obtain 6,7...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an 8-hydroxyquinoline derivative iridium (III) complex as well as a preparation method and application thereof, and belongs to the field of medicines. The chemical name of the compound is 2-methylpyridino[3,2-a]-pyridino[1',2':1,2]imidazo[4,5-c]phenazine.bisbenzoquinolinyl iridium(III) hexafluorophosphate . The preparation method comprises the following steps: reacting 8-hydroxyquinoline with hydrochloric acid and NaClO3; adding anhydrous potassium carbonate; adding 2-amino-5-methylpyridine; adding o-phenylenediamine; obtaining a compound 3a; reacting 7,8-benzoquinoline with iridium trichloride hydrate to obtain a compound 4; and reacting the compound 3a with a compound 4 to obtain the 8-hydroxyquinoline derivative iridium (III) complex. The in-vitro anti-tumor activity of the compound on a human ovarian cancer drug-resistant strain SK-OV-3 / DDP is greater than that of an 8-hydroxyquinoline derivative ligand and a metal-based anti-cancer drug cis-platinum; and the toxicity to normal cells HL-7702 is very low, and a good effect of targeted inhibition of human ovarian cancer proliferation is reflected.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to an 8-hydroxyquinoline derivative iridium (III) complex and a preparation method and application thereof. Background technique [0002] Although platinum-based drugs have achieved great success in the clinical application of cancer treatment, platinum-based drugs have the disadvantages of serious toxic side effects and easy drug resistance. Therefore, medicinal chemists have been searching for atypical platinum and non-platinum drugs with high efficacy and low toxicity. 8-Hydroxyquinoline and its derivative metal complexes have attracted extensive interest of medicinal chemistry researchers in recent years due to their strong antitumor activity and diverse action mechanisms. [0003] Quinolines (quinolines) alkaloids are a class of alkaloids with a quinoline ring as the basic nucleus, such as the antimalarial drug quinine and the anticancer drug camptothecin. And 8-hydroxyquino...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07F15/00A61P35/00
Inventor 杨燕宾贻东廖志强农基健
Owner YULIN NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products